Drugs / Wuling Powder
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04812236 | Apr 2021 → Feb 2023 | metabolic syndrome X | Jiangsu Famous Medical Technology Co., Ltd. | Unknown | No outcome recorded |
| Phase 4 | NCT03195231 | Jun 2017 → Dec 2019 | antidepressant type abuse | Beijing Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wuling Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03195231 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Wuling powder is a Chinese medicine which is made by cultivating Xylariasp mycelium using submerged fermentation technology.” NCT03195231 ↗ |